SquamousCellCarcinomaofSkin near Fishkill, NY
We found 967 results within 50 miles for "SquamousCellCarcinomaofSkin near Fishkill, NY"
- Appt. wasn't rushed (18)
- Listened/answered questions (18)
- Explains conditions well (18)
- View 2 more provider attributes

- Listened/answered questions (64)
- Explains conditions well (64)
- Found trustworthy (64)
- View 2 more provider attributes

- Listened/answered questions (22)
- Explains conditions well (21)
- Appt. wasn't rushed (19)
- View 1 more provider attributes
- Offers Telehealth

- Found trustworthy (26)
- Appt. wasn't rushed (25)
- Listened/answered questions (25)
- View 1 more provider attributes
- Offers Telehealth

- Explains conditions well (4)

- Offers Telehealth

- Appt. wasn't rushed (31)
- Listened/answered questions (31)
- Explains conditions well (31)
- View 1 more provider attributes

- Appt. wasn't rushed (3)
- Listened/answered questions (3)
- Explains conditions well (3)
- View 1 more provider attributes
- Offers Telehealth
Biography: Dr. Khalid Dar, MD is an Oncology Specialist who practices in New York, NY. He is 75 years old and has been practicing for 51 years. Dr. Khalid Dar, MD is affiliated with Mount Sinai Morningside.

- Explains conditions well (33)
- Found trustworthy (33)
- Appt. wasn't rushed (32)
- View 2 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (1)
- Listened/answered questions (1)
- Explains conditions well (1)
- View 1 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (15)
- Listened/answered questions (15)
- Explains conditions well (15)
- View 2 more provider attributes
- Offers Telehealth
Biography: Nicole Lamanna, MD, is an Associate Clinical Professor of Medicine in the Hematologic Malignancies Section of the Hematology/Oncology Division. Dr. Lamanna is a hematologist/oncologist whose research interests include lymphoid leukemias, specifically chronic lymphocytic leukemia. She is an experienced clinical investigator and her research focus has been the development of combination therapies that include chemoimmunotherapy, immunomodulatory drugs, novel kinase inhibitors and monoclonal antibodies. She also is working to find active, safer therapies for older patients with these diseases. She earned her medical degree from Albert Einstein College of Medicine and completed her fellowship in Hematology-Oncology at Memorial Sloan-Kettering Cancer Center.

- Appt. wasn't rushed (4)
- Listened/answered questions (4)
- Explains conditions well (4)
- View 1 more provider attributes

- Listened/answered questions (37)
- Found trustworthy (37)
- Appt. wasn't rushed (35)
- View 1 more provider attributes

- Appt. wasn't rushed (1)
- Listened/answered questions (1)
- Explains conditions well (1)
- View 2 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (2)
- Listened/answered questions (2)
- Explains conditions well (2)
- View 2 more provider attributes

- Appt. wasn't rushed (4)
- Listened/answered questions (4)
- Explains conditions well (4)
- View 1 more provider attributes
- Offers Telehealth

- Listened/answered questions (18)
- Explains conditions well (18)
- Appt. wasn't rushed (1)
- View 2 more provider attributes
- Offers Telehealth

- Found trustworthy (26)
- Appt. wasn't rushed (25)
- Listened/answered questions (25)
- View 2 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (19)
- Listened/answered questions (19)
- Explains conditions well (19)
- View 2 more provider attributes
- Offers Telehealth

- Found trustworthy (30)
- Listened/answered questions (29)
- Explains conditions well (28)
- View 2 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (9)
- Listened/answered questions (9)
- Explains conditions well (9)
- View 1 more provider attributes

- Listened/answered questions (14)
- Explains conditions well (14)
- Found trustworthy (14)
- View 2 more provider attributes
- Offers Telehealth
Biography: Dr. Stein is an Associate Professor of Medical Oncology at Columbia University Medical Center. He is a recognized expert in field of genitourinary oncology treating patients with prostate, kidney, bladder and testicular cancers. He is also a member of the Experimental Therapeutics program, investigating novel therapies across all solid tumors. In addition to providing standard therapies for the treatment of genitourinary cancers such as hormonal therapy, molecularly targeted therapy and chemotherapy, Dr. Stein leads multiple investigator initiated and industry sponsored clinical trials. Dr. Stein has a particular interest in the development of novel immune therapies for the treatment of prostate cancer, both in men with early recurrence of prostate cancer as well as in men with more advanced prostate cancer. He is also helping to lead two national trials in kidney cancer sponsored by the National Cancer Institute. Dr. Stein received his B.S. in Molecular Biophysics and Biochemistry from Yale University. He earned his medical degree at New York Medical College, receiving the graduation award in oncology for his published research. He completed a residency in internal medicine at Montefiore Medical Center, and a fellowship in Hematology and Medical Oncology at Mount Sinai Medical Center. Prior to joining Columbia University, Dr. Stein practiced genitourinary oncology for 13 years at Rutgers University and has been an author on over 60 publications including guidelines for assessing the efficacy of new drugs in prostate cancer and recommendations for the use of immunotherapy to treat prostate cancer.
